Clinical Trials Logo

Massive Pulmonary Embolism clinical trials

View clinical trials related to Massive Pulmonary Embolism.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04688320 Completed - Clinical trials for Massive Pulmonary Embolism

Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE

Start date: December 15, 2020
Phase: Phase 3
Study type: Interventional

Objective: to evaluate the efficacy and safety of the Recombinant Non-immunogenic Staphylokinase with its single bolus administration in comparison with the bolus-infusion administration of the Alteplase in patients with massive pulmonary embolism

NCT ID: NCT02692586 Completed - Pulmonary Embolism Clinical Trials

FlowTriever Pulmonary Embolectomy Clinical Study

FLARE
Start date: April 2016
Phase: N/A
Study type: Interventional

Evaluate the safety and effectiveness of the FlowTriever System for use in the removal of emboli from the pulmonary arteries in the treatment of acute pulmonary embolism.

NCT ID: NCT01513759 Completed - Pulmonary Embolism Clinical Trials

Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy

SEATTLE II
Start date: June 7, 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if the EKOS EkoSonic® Endovascular Device when used in conjunction with recombinant tissue plasminogen activator (t-PA) as a treatment for acute PE will decrease the ratio of right ventricle (RV) to left ventricle (LV) diameter within 48 =/- 6 hours in participants with massive or submassive PE.